Latest Insider Transactions at Global Blood Therapeutics, Inc. (GBT)
This section provides a real-time view of insider transactions for Global Blood Therapeutics, Inc. (GBT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Global Blood Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Global Blood Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,506
-14.78%
|
$130,674
$29.33 P/Share
|
|
Feb 01
2022
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+22.84%
|
-
|
|
Feb 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,470
-9.41%
|
$100,630
$29.33 P/Share
|
|
Feb 01
2022
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,395
+20.31%
|
-
|
|
Oct 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,170
-5.26%
|
$56,420
$26.25 P/Share
|
|
Oct 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+9.59%
|
-
|
|
Sep 09
2021
|
Scott W Morrison Director |
SELL
Open market or private sale
|
Direct |
4,800
-61.25%
|
$144,000
$30.21 P/Share
|
|
Sep 01
2021
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,683
-0.59%
|
$135,807
$29.85 P/Share
|
|
Sep 01
2021
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,444
+1.17%
|
-
|
|
Sep 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,370
-6.0%
|
$39,730
$29.85 P/Share
|
|
Sep 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+10.79%
|
-
|
|
Sep 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,047
-3.67%
|
$30,363
$29.85 P/Share
|
|
Sep 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+8.83%
|
-
|
|
Sep 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,072
-2.83%
|
$31,088
$29.85 P/Share
|
|
Sep 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+6.79%
|
-
|
|
Sep 01
2021
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,370
-0.74%
|
$39,730
$29.85 P/Share
|
|
Sep 01
2021
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,762
+1.47%
|
-
|
|
Aug 31
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.17%
|
$1,032
$24.39 P/Share
|
|
Aug 31
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
480
+1.35%
|
$11,520
$24.39 P/Share
|
|
Aug 31
2021
|
Jung Choi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.07%
|
$3,072
$24.39 P/Share
|
|
Aug 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,250
-11.22%
|
$87,750
$27.33 P/Share
|
|
Aug 01
2021
|
Tricia Borga Suvari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,395
+24.49%
|
-
|
|
Aug 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,342
-6.32%
|
$63,234
$27.33 P/Share
|
|
Aug 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+15.45%
|
-
|
|
Aug 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,354
-17.83%
|
$117,558
$27.33 P/Share
|
|
Aug 01
2021
|
Jeffrey S Farrow Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+26.97%
|
-
|
|
Aug 01
2021
|
Jung Choi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,743
-2.01%
|
$101,061
$27.33 P/Share
|
|
Aug 01
2021
|
Jung Choi Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,020
+4.62%
|
-
|
|
Aug 01
2021
|
Ted W Love President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,853
-1.85%
|
$401,031
$27.33 P/Share
|
|
Aug 01
2021
|
Ted W Love President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,955
+3.59%
|
-
|
|
Jun 18
2021
|
Philip A. Pizzo Director |
SELL
Open market or private sale
|
Direct |
1,065
-13.59%
|
$38,340
$36.54 P/Share
|
|
Jun 18
2021
|
Dawn Svoronos Director |
SELL
Open market or private sale
|
Direct |
1,609
-30.4%
|
$57,924
$36.54 P/Share
|
|
Jun 17
2021
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+27.93%
|
-
|
|
Jun 17
2021
|
Scott W Morrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+27.93%
|
-
|
|
Jun 17
2021
|
Philip A. Pizzo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+27.93%
|
-
|
|
Jun 17
2021
|
Deval L Patrick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+35.84%
|
-
|
|
Jun 17
2021
|
Willie L. Brown Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+7.18%
|
-
|
|
Jun 17
2021
|
Glenn Pierce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+11.74%
|
-
|
|
Jun 17
2021
|
Mark L Perry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+8.14%
|
-
|
|
Jun 17
2021
|
Dawn Svoronos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+36.46%
|
-
|
|
May 10
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Open market or private purchase
|
Direct |
500
+8.83%
|
$18,500
$37.96 P/Share
|
|
Apr 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-4.76%
|
$63,546
$42.62 P/Share
|
|
Apr 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+12.1%
|
-
|
|
Mar 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,297
-9.75%
|
$57,068
$44.48 P/Share
|
|
Mar 01
2021
|
Brian Edwin Cathers Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+21.99%
|
-
|
|
Mar 01
2021
|
Eric Fink Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
859
-15.56%
|
$37,796
$44.48 P/Share
|
|
Mar 01
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+36.15%
|
-
|
|
Feb 28
2021
|
Ted W Love President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
370
+0.05%
|
$13,320
$36.21 P/Share
|
|
Feb 28
2021
|
Jung Choi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140
+0.08%
|
$5,040
$36.21 P/Share
|
|
Feb 28
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.35%
|
$13,500
$36.21 P/Share
|